| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |